RU2020128838A - Композиции и способы для индуцирования передачи сигнала белка, содержащего трехсторонний мотив, 16 (trim16) - Google Patents
Композиции и способы для индуцирования передачи сигнала белка, содержащего трехсторонний мотив, 16 (trim16) Download PDFInfo
- Publication number
- RU2020128838A RU2020128838A RU2020128838A RU2020128838A RU2020128838A RU 2020128838 A RU2020128838 A RU 2020128838A RU 2020128838 A RU2020128838 A RU 2020128838A RU 2020128838 A RU2020128838 A RU 2020128838A RU 2020128838 A RU2020128838 A RU 2020128838A
- Authority
- RU
- Russia
- Prior art keywords
- nucleic acid
- cell
- cancer
- trim16
- arm region
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/17—Immunomodulatory nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862625623P | 2018-02-02 | 2018-02-02 | |
| US62/625,623 | 2018-02-02 | ||
| PCT/US2019/016413 WO2019152884A1 (en) | 2018-02-02 | 2019-02-01 | Compositions and methods for inducing tripartite motif-containing protein 16 (trim16) signaling |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2020128838A true RU2020128838A (ru) | 2022-03-03 |
| RU2020128838A3 RU2020128838A3 (cg-RX-API-DMAC7.html) | 2022-07-14 |
Family
ID=67479930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2020128838A RU2020128838A (ru) | 2018-02-02 | 2019-02-01 | Композиции и способы для индуцирования передачи сигнала белка, содержащего трехсторонний мотив, 16 (trim16) |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210046168A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3746088B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7409612B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102828978B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111836623A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019215191B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020015821A2 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2020128838A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019152884A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11679163B2 (en) | 2019-09-20 | 2023-06-20 | Hdt Bio Corp. | Compositions and methods for delivery of RNA |
| WO2021194672A1 (en) | 2020-03-23 | 2021-09-30 | Hdt Bio Corp. | Compositions and methods for delivery of rna |
| JP2022550454A (ja) * | 2019-10-02 | 2022-12-01 | ユニバーシティ オブ ワシントン | B型肝炎ウイルス感染の治療のための組成物及び方法 |
| EP4058581A1 (en) * | 2019-11-15 | 2022-09-21 | Infectious Disease Research Institute | Rig-i agonist and adjuvant formulation for tumor treatment |
| EP4112665A4 (en) * | 2020-03-27 | 2024-04-10 | Mitsui Chemicals, Inc. | LIGHT-CURING COMPOSITION, CURED PRODUCT AND DENTAL PRODUCT |
| KR20240043747A (ko) | 2021-07-02 | 2024-04-03 | 예일 유니버시티 | 암을 치료하기 위한 조성물 및 방법 |
| JP2024532621A (ja) | 2021-08-31 | 2024-09-05 | イエール ユニバーシティ | がんを治療するための組成物および方法 |
| AU2022352486A1 (en) | 2021-09-22 | 2024-04-11 | Hdt Bio Corp. | Dried nanoparticle compositions |
| CA3232658A1 (en) | 2021-09-22 | 2023-03-30 | Steven Gregory REED | Rna vaccines against infectious diseases |
| WO2023049636A2 (en) | 2021-09-22 | 2023-03-30 | Hdt Bio Corp. | Cancer therapy compositions and uses thereof |
| JP2024535352A (ja) | 2021-09-22 | 2024-09-30 | エイチディーティー バイオ コーポレーション | Sars-cov-2 rnaワクチン組成物および使用方法 |
| AU2023228912A1 (en) | 2022-03-03 | 2024-09-19 | Yale University | Humanized 3e10 antibodies, variants, and antigen binding fragments thereof |
| WO2026039779A1 (en) | 2024-08-15 | 2026-02-19 | Yale University | Humanized 3e10 antibodies and antigen binding fragments optimized for rad51 binding |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003218181A1 (en) | 2002-03-15 | 2003-09-29 | Multicell Immunotherapeutics, Inc. | Immunostimulatory double stranded RNA and methods of inducing, enhancing or modulating the immune response |
| JP2010500011A (ja) | 2006-08-08 | 2010-01-07 | ガンサー ハートマン | 5’リン酸オリゴヌクレオチドの構造および使用 |
| BRPI1100857A2 (pt) * | 2011-03-18 | 2013-05-21 | Eduardo Nowill Alexandre | agente imunomodulador e suas combinaÇÕes, seu uso e mÉtodo imunoterÁpico para a recontextualizaÇço, reprogramaÇço e reconduÇço do sistema imune em tempo real |
| US9775894B2 (en) * | 2013-07-09 | 2017-10-03 | University Of Washington Through Its Center For Commercialization | Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling |
| US10624964B2 (en) * | 2015-05-01 | 2020-04-21 | The Trustees Of The University Of Pennsylvania | Methods and compositions for stimulating immune response using potent immunostimulatory RNA motifs |
| CN117244049A (zh) * | 2016-02-16 | 2023-12-19 | 哈佛学院院长等 | 病原体疫苗及其生产和使用方法 |
-
2019
- 2019-02-01 AU AU2019215191A patent/AU2019215191B2/en active Active
- 2019-02-01 KR KR1020207025399A patent/KR102828978B1/ko active Active
- 2019-02-01 US US16/966,851 patent/US20210046168A1/en active Pending
- 2019-02-01 WO PCT/US2019/016413 patent/WO2019152884A1/en not_active Ceased
- 2019-02-01 JP JP2020541958A patent/JP7409612B2/ja active Active
- 2019-02-01 RU RU2020128838A patent/RU2020128838A/ru unknown
- 2019-02-01 BR BR112020015821-6A patent/BR112020015821A2/pt unknown
- 2019-02-01 CN CN201980018082.3A patent/CN111836623A/zh active Pending
- 2019-02-01 EP EP19748292.0A patent/EP3746088B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3746088B1 (en) | 2024-07-10 |
| KR20200116976A (ko) | 2020-10-13 |
| KR102828978B1 (ko) | 2025-07-02 |
| WO2019152884A1 (en) | 2019-08-08 |
| EP3746088A1 (en) | 2020-12-09 |
| EP3746088C0 (en) | 2024-07-10 |
| JP2021512123A (ja) | 2021-05-13 |
| JP7409612B2 (ja) | 2024-01-09 |
| US20210046168A1 (en) | 2021-02-18 |
| EP3746088A4 (en) | 2023-02-22 |
| AU2019215191B2 (en) | 2025-08-14 |
| AU2019215191A1 (en) | 2020-09-17 |
| CN111836623A (zh) | 2020-10-27 |
| BR112020015821A2 (pt) | 2021-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512123A5 (cg-RX-API-DMAC7.html) | ||
| US20240066096A1 (en) | pHLIP® peptide mediated epitope tethering at cell surfaces | |
| WO2021147121A1 (zh) | 修饰的免疫细胞及其应用 | |
| RU2007136026A (ru) | Варианты ил-21 | |
| CA2361009A1 (en) | Her-2/neu fusion proteins | |
| JP2023539871A5 (cg-RX-API-DMAC7.html) | ||
| JP2021525549A5 (cg-RX-API-DMAC7.html) | ||
| JP2023510121A5 (cg-RX-API-DMAC7.html) | ||
| JP2024513559A5 (cg-RX-API-DMAC7.html) | ||
| Kawakatsu et al. | Human carcinoma cells synthesize and secrete tenascin in vitro | |
| WO2012144726A2 (ko) | 폴로-유사 키나아제 1의 종양항원 단백질 또는 유전자 | |
| CN114302962A (zh) | 特异性针对来源于ebv抗原的tcr构建体 | |
| JP2023523083A5 (cg-RX-API-DMAC7.html) | ||
| JP2022507373A5 (cg-RX-API-DMAC7.html) | ||
| US8802619B2 (en) | Cancer vaccine | |
| WO2017035251A1 (en) | T cells modified to overexpress c-myb | |
| RU2004122084A (ru) | Пептиды для лечения рака, ассоциированного с папилломавирусом (hpv) человека, и других эпителиальных опухолей | |
| CN107875376A (zh) | 包含ny‑eso‑1的微泡、其制备方法及用途 | |
| FI3335725T3 (fi) | Pds5a-epitooppeja immuuniteetin indusoijina | |
| JP2024528029A5 (cg-RX-API-DMAC7.html) | ||
| JP2023502843A5 (cg-RX-API-DMAC7.html) | ||
| CN111118063B (zh) | 以FAPα和survivin为基础的DNA及其在制备肿瘤疫苗中的应用 | |
| CN119770633A (zh) | 一种改进型多肽肿瘤疫苗组成与应用 | |
| CN117797253A (zh) | 一种能扩展t细胞抗原表位的肿瘤疫苗及其制备方法 | |
| US8207141B2 (en) | Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof |